Druggable	Report_C1	Report_C2	Tumor_VAF	Normal_VAF	DP_T	DP_N	SF_TVAF	SF_TDP	CHROM	Start	End	REF	ALT	FILTER	Gene	Transcript	Exon/Intron_Number	cHGVS	pHGVS	Type_Annotation	CLNSIG	CLNCONF	CLNDN	MPOS	POSD
	SPEN(28.6%)	exon6,c.1329C>T,p.G443=	0.286	0.015	837|328	175|1	0.28167	1066|418	1	16242708	16242708	C	T	PASS	SPEN	NM_015001.3	6	c.1329C>T	p.Gly443=	synonymous_variant				42	0.0
	SPEN(7.2%)	exon11,c.9102C>A,p.S3034=	0.072	0.126	52|5	8|0	0.07937	58|5	1	16261837	16261837	C	A	PASS	SPEN	NM_015001.3	11	c.9102C>A	p.Ser3034=	synonymous_variant				55	0.0
-	ARID1A(68.2%)	exon20,c.5548del,p.D1850fs	0.682	0.068	50|106	14|0	0.64646	70|128	1	27105930	27105931	TG	T	distinguished	ARID1A	NM_006015.6	20	c.5548del	p.Asp1850fs	frameshift_variant				38	0.0
	JAK1(7.8%)	exon7,c.936C>T,p.Y312=	0.078	0.002085	2974|243	606|0	0.07632	4732|391	1	65332603	65332603	G	A	PASS	JAK1	NM_002227.4	7	c.936C>T	p.Tyr312=	synonymous_variant				34	0.0
	CDC7(0.5%)	exon2,c.84A>T,p.L28F	0.005266	0.003902	3133|21	669|3	0.03750	5493|214	1	91967357	91967357	A	T	background,low_allele_frac	CDC7	NM_003503.4	2	c.84A>T	p.Leu28Phe	missense_variant				27	0.0
	SPTA1(23.6%)	exon15,c.1952G>A,p.G651D	0.236	0.083	32|8	12|0	0.25581	32|11	1	158637734	158637734	C	T	PASS	SPTA1	NM_003126.4	15	c.1952G>A	p.Gly651Asp	missense_variant				35	0.0
	SPTA1(31.0%)	exon13,c.1669C>T,p.R557C	0.31	0.046	39|17	24|0	0.32203	40|19	1	158639507	158639507	G	A	PASS	SPTA1	NM_003126.4	13	c.1669C>T	p.Arg557Cys	missense_variant	Uncertain_significance		not_provided	33	0.0
	FMN2(3.6%)	exon5,c.2757_2822del,p.I920_G941del	0.036	0.031	188|5	32|0	0.00000	36|0	1	240370857	240370923	TCCCGGAGCGGGCATACCTCCTCCGCCGCCTCTACCCGGAGCAGGCATACTCCCTCTGCCCCCTCTA	T	PASS	FMN2	NM_020066.5	5	c.2757_2822del	p.Ile920_Gly941del	disruptive_inframe_deletion				40	0.0
	TAF1B(5.3%)	exon3,c.195_197del,p.K65del	0.053	0.006583	389|63	125|0	0.06899	1282|95	2	9989570	9989573	TAAA	T	multiallelic	TAF1B	NM_005680.3	3	c.195_197del	p.Lys65del	disruptive_inframe_deletion				39	0.0
	TAF1B(49.8%)	exon3,c.196_197del,p.N66fs	0.498	0.02	389|589	125|2	0.44765	1282|1039	2	9989570	9989573	TAAA	TA	multiallelic	TAF1B	NM_005680.3	3	c.196_197del	p.Asn66fs	frameshift_variant				39	0.0
	TAF1B(8.5%)	exon3,c.197del,p.N66fs	0.085	0.193	389|115	125|41	0.13902	1282|207	2	9989570	9989573	TAAA	TAA	multiallelic,suspected_bg	TAF1B	NM_005680.3	3	c.197del	p.Asn66fs	frameshift_variant				39	0.0
	DNMT3A(2.1%)	exon3,c.132G>A,p.T44=	0.021	0.03	267|5	49|0	0.01923	306|6	2	25523053	25523053	C	T	PASS	DNMT3A	NM_022552.5	3	c.132G>A	p.Thr44=	synonymous_variant				17	0.0
	ALK(3.4%)	exon1,c.474del,p.E160fs	0.034	0.059	196|5	22|1	0.02632	222|6	2	30143051	30143052	CG	C	distinguished	ALK	NM_004304.5	1	c.474del	p.Glu160fs	frameshift_variant	Uncertain_significance		Neuroblastoma,_susceptibility_to,_3	33	0.0
-	MSH2(24.1%)	exon2,c.212-7_212-4del	0.241	0.03	48|228	27|0	0.53322	267|305	2	47635523	47635527	CTTTT	C	multiallelic	MSH2	NM_000251.3	1	c.212-7_212-4del		splice_region_variant&intron_variant				39	0.0
-	MSH2(41.8%)	exon2,c.212-6_212-4del	0.418	0.036	48|379	27|0	0.68477	267|580	2	47635523	47635527	CTTTT	CT	multiallelic	MSH2	NM_000251.3	1	c.212-6_212-4del		splice_region_variant&intron_variant				40	0.0
-	MSH2(25.9%)	exon2,c.212-5_212-4del	0.259	0.061	48|232	27|1	0.62181	267|439	2	47635523	47635527	CTTTT	CTT	multiallelic	MSH2	NM_000251.3	1	c.212-5_212-4del		splice_region_variant&intron_variant	Likely_benign		not_specified	42	0.0
-	MSH2(2.2%)	exon2,c.212-4del	0.022	0.104	48|21	27|4	0.17337	267|56	2	47635523	47635527	CTTTT	CTTT	multiallelic,suspected_bg	MSH2	NM_000251.3	1	c.212-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Lynch_syndrome_1|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided	53	0.0
-	MSH6(5.1%)	exon5,c.3261del,p.F1088fs	0.051	0.041	1580|121	378|16	0.05494	3819|222	2	48030639	48030640	AC	A	multiallelic,slippage,suspected_bg	MSH6	NM_000179.3	5	c.3261del	p.Phe1088fs	frameshift_variant	Pathogenic		Lynch-like_syndrome|Endometrial_carcinoma|Carcinoma_of_colon|Lynch_syndrome|Colorectal_cancer,_hereditary_nonpolyposis,_type_5|Hereditary_cancer-predisposing_syndrome|Mismatch_repair_cancer_syndrome_3|Hereditary_nonpolyposis_colorectal_neoplasms|not_provided	50	0.0
-	MSH6(13.7%)	exon5,c.3261dup,p.F1088fs	0.137	0.002966	1580|275	378|0	0.15020	3819|675	2	48030639	48030640	AC	ACC	multiallelic,slippage,distinguished	MSH6	NM_000179.3	5	c.3261dup	p.Phe1088fs	frameshift_variant	Pathogenic		Lynch-like_syndrome|Lynch_syndrome|Colorectal_cancer,_hereditary_nonpolyposis,_type_5|Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms|not_provided	44	0.0
-	MSH6(1.2%)	exon5,c.3260_3261dup,p.F1088fs	0.012	0.002936	1580|25	378|0	0.02577	3819|101	2	48030639	48030640	AC	ACCC	multiallelic,slippage	MSH6	NM_000179.3	5	c.3260_3261dup	p.Phe1088fs	frameshift_variant	Pathogenic		Hereditary_cancer-predisposing_syndrome	46	0.0
	RANBP2(2.3%)	exon10,c.1398T>G,p.H466Q	0.023	0.026	278|6	47|0	0.06878	352|26	2	109367844	109367844	T	G	background	RANBP2	NM_006267.5	10	c.1398T>G	p.His466Gln	missense_variant	Uncertain_significance		Familial_acute_necrotizing_encephalopathy	27	0.0
	RANBP2(11.0%)	exon15,c.2143A>G,p.R715G	0.11	0.019	291|36	62|0	0.10499	341|40	2	109370368	109370368	A	G	PASS	RANBP2	NM_006267.5	15	c.2143A>G	p.Arg715Gly	missense_variant				34	0.0
	TMEM37(29.3%)	exon2,c.422G>A,p.G141E	0.293	0.048	86|32	22|0	0.28235	122|48	2	120194865	120194865	G	A	PASS	TMEM37	NM_183240.3	2	c.422G>A	p.Gly141Glu	missense_variant				52	0.0
	LRP1B(31.4%)	exon77,c.11880C>A,p.N3960K	0.314	0.019	129|58	69|0	0.34322	155|81	2	141108378	141108378	G	T	PASS	LRP1B	NM_018557.3	77	c.11880C>A	p.Asn3960Lys	missense_variant				42	0.0
	LRP1B(1.4%)	exon21,c.3214C>T,p.R1072C	0.014	0.005832	597|9	187|0	0.01872	734|14	2	141680639	141680639	G	A	PASS	LRP1B	NM_018557.3	21	c.3214C>T	p.Arg1072Cys	missense_variant				49	0.0
	LRP1B(24.1%)	exon10,c.1504C>T,p.R502C	0.241	0.027	155|49	49|0	0.29289	169|70	2	141812733	141812733	G	A	PASS	LRP1B	NM_018557.3	10	c.1504C>T	p.Arg502Cys	missense_variant				43	0.0
	ERBB4(25.8%)	exon26,c.3180A>G,p.S1060=	0.258	0.006582	673|227	207|0	0.25342	872|296	2	212252673	212252673	T	C	PASS	ERBB4	NM_005235.3	26	c.3180A>G	p.Ser1060=	synonymous_variant				41	0.0
	BARD1(3.9%)	exon8,c.1788del,p.K596fs	0.039	0.04	155|7	28|0	0.04167	184|8	2	215610467	215610468	AT	A	distinguished	BARD1	NM_000465.4	8	c.1788del	p.Lys596fs	frameshift_variant	Likely_pathogenic		Familial_cancer_of_breast	32	0.0
	BARD1(2.1%)	exon8,c.1760A>G,p.E587G	0.021	0.032	197|4	41|0	0.01732	227|4	2	215610496	215610496	T	C	PASS	BARD1	NM_000465.4	8	c.1760A>G	p.Glu587Gly	missense_variant				62	0.0
	UGT1A1(0.8%)	exon,c.-55_-54insAT	0.008452	0.016	3520|34	801|13	0.00730	11823|87	2	234668879	234668881	CAT	CATAT	clustered_events,multiallelic,normal_artifact,suspected_bg,chemotherapy_site	UGT1A1	NM_000463.3		c.-55_-54insAT		upstream_gene_variant	Conflicting_interpretations_of_pathogenicity|_drug_response|_other	Pathogenic(7)|_Uncertain_significance(1)|_Benign(3)	Gilbert_syndrome|Lucey-Driscoll_syndrome|Crigler-Najjar_syndrome,_type_II|Crigler-Najjar_syndrome_type_1|Bilirubin,_serum_level_of,_quantitative_trait_locus_1|Irinotecan_response|not_specified|not_provided	44	0.0
	TGFBR2(75.6%)	exon4,c.457_458del,p.K153fs	0.756	0.025	89|388	86|2	0.70926	223|544	3	30691871	30691873	GAA	G	multiallelic	TGFBR2	NM_001024847.2	4	c.457_458del	p.Lys153fs	frameshift_variant				39	0.0
	TGFBR2(5.5%)	exon4,c.458del,p.K153fs	0.055	0.113	89|28	86|11	0.19784	223|55	3	30691871	30691873	GAA	GA	multiallelic,suspected_bg	TGFBR2	NM_001024847.2	4	c.458del	p.Lys153fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(1)|_Benign(3)|_Likely_benign(1)	Loeys-Dietz_syndrome|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_specified|Cardiovascular_phenotype|not_provided	38	0.0
	CTNNB1(32.8%)	exon9,c.1493T>C,p.L498S	0.328	0.006111	852|417	224|0	0.33969	1211|623	3	41275327	41275327	T	C	PASS	CTNNB1	NM_001904.4	9	c.1493T>C	p.Leu498Ser	missense_variant				35	0.0
	ANO10(7.1%)	exon2,c.132del,p.D45fs	0.071	0.025	1924|166	568|12	0.06884	3544|262	3	43647212	43647213	CT	C	haplotype,normal_artifact,slippage,suspected_bg	ANO10	NM_018075.5	2	c.132del	p.Asp45fs	frameshift_variant	Pathogenic		not_provided	47	0.0
	ANO10(0.9%)	exon2,c.132A>G,p.K44=	0.008846	0.007129	2145|22	596|5	0.07886	3703|317	3	43647213	43647213	T	C	background	ANO10	NM_018075.5	2	c.132A>G	p.Lys44=	synonymous_variant				47	0.0
-	SETD2(30.4%)	exon12,c.5438del,p.N1813fs	0.304	0.067	78|29	17|0	0.26761	104|38	3	47125831	47125832	AT	A	PASS	SETD2	NM_014159.7	12	c.5438del	p.Asn1813fs	frameshift_variant				35	0.0
-	SETD2(35.1%)	exon3,c.843del,p.E282fs	0.351	0.024	195|111	44|0	0.34465	251|132	3	47165282	47165283	CT	C	PASS	SETD2	NM_014159.7	3	c.843del	p.Glu282fs	frameshift_variant				33	0.0
	SLC35G2(34.8%)	exon2,c.192del,p.R66fs	0.348	0.03	565|300	167|4	0.33548	929|469	3	136573485	136573486	GA	G	distinguished	SLC35G2	NM_001097599.2	2	c.192del	p.Arg66fs	frameshift_variant				43	0.0
	ATR(45.5%)	exon10,c.2320del,p.I774fs	0.455	0.062	2161|1904	748|61	0.39020	5265|3369	3	142274739	142274740	AT	A	multiallelic,normal_artifact,distinguished	ATR	NM_001184.4	10	c.2320del	p.Ile774fs	frameshift_variant	Pathogenic		Endometrial_neoplasm|not_provided	42	0.0
	ATR(0.6%)	exon10,c.2320dup,p.I774fs	0.005688	0.017	2161|36	748|14	0.02319	5265|125	3	142274739	142274740	AT	ATT	multiallelic,normal_artifact,suspected_bg,low_allele_frac	ATR	NM_001184.4	10	c.2320dup	p.Ile774fs	frameshift_variant	Pathogenic		not_provided	42	0.0
1	PIK3CA(0.1%)	exon10,c.1624G>A,p.E542K	0.001377	0.0009199	3651|5	1445|0	0.00099	7032|7	3	178936082	178936085	G	A	clustered_events,orientation,weak_evidence,background	PIK3CA	NM_006218.4	10	c.1624G>A	p.Glu542Lys	missense_variant	Pathogenic		CEREBRAL_CAVERNOUS_MALFORMATIONS_4,_SOMATIC|Cerebrofacial_Vascular_Metameric_Syndrome_(CVMS)|Hepatocellular_carcinoma|Abnormality_of_cardiovascular_system_morphology|Transitional_cell_carcinoma_of_the_bladder|Breast_neoplasm|Carcinoma_of_esophagus|Lung_adenocarcinoma|Small_cell_lung_carcinoma|Non-small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Neoplasm_of_brain|Neoplasm_of_uterine_cervix|Gastric_adenocarcinoma|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Prostate_adenocarcinoma|Squamous_cell_carcinoma_of_the_head_and_neck|CLOVES_syndrome|CLAPO_syndrome|Glioblastoma|Lip_and_oral_cavity_carcinoma|Overgrowth_syndrome_and/or_cerebral_malformations_due_to_abnormalities_in_MTOR_pathway_genes|Papillary_renal_cell_carcinoma,_sporadic|Malignant_neoplasm_of_body_of_uterus|not_provided	63	0.0
	CLDN16(0.4%)	exon1,c.40T>C,p.F14L	0.004296	0.00521	3778|18	727|2	0.01004	6603|67	3	190106158	190106158	T	C	low_allele_frac	CLDN16	NM_006580.4	1	c.40T>C	p.Phe14Leu	missense_variant				49	0.0
	PDGFRA(24.4%)	exon9,c.1323G>A,p.P441=	0.244	0.004006	1372|455	324|0	0.25662	2022|698	4	55138646	55138646	G	A	PASS	PDGFRA	NM_006206.6	9	c.1323G>A	p.Pro441=	synonymous_variant	Likely_benign		Gastrointestinal_stromal_tumor|Hereditary_cancer-predisposing_syndrome	40	0.0
1	KIT(0.1%)	exon14,c.2009C>T,p.T670I	0.001308	0.001019	4032|4	1364|0	0.00215	8348|18	4	55595519	55595519	C	T	orientation,strand_bias,weak_evidence	KIT	NM_000222.3	14	c.2009C>T	p.Thr670Ile	missense_variant	Likely_pathogenic		Gastrointestinal_stromal_tumor	48	0.0
	EPHA5(4.9%)	exon6,c.1448dup,p.N483fs	0.049	0.021	204|10	49|0	0.04895	272|14	4	66286237	66286237	G	GT	PASS	EPHA5	NM_004439.8	6	c.1448dup	p.Asn483fs	frameshift_variant				30	0.0
	TERT(31.8%)	exon10,c.2654+2T>C	0.318	0.025	249|111	47|0	0.28043	331|129	5	1266577	1266577	A	G	PASS	TERT	NM_198253.3	10	c.2654+2T>C		splice_donor_variant&intron_variant				33	0.0
	IL7R(2.0%)	exon4,c.396T>C,p.P132=	0.02	0.033	277|5	38|0	0.01918	358|7	5	35871174	35871174	T	C	PASS	IL7R	NM_002185.5	4	c.396T>C	p.Pro132=	synonymous_variant				31	0.0
	RICTOR(0.2%)	exon21,c.1927G>A,p.E643K	0.002195	0.001853	4198|11	1376|2	0.00217	8259|18	5	38960005	38960005	C	T	low_allele_frac	RICTOR	NM_152756.5	21	c.1927G>A	p.Glu643Lys	missense_variant				42	0.0
	MSH3(33.5%)	exon7,c.1148del,p.K383fs	0.335	0.014	2357|1220	931|16	0.31815	4312|2012	5	79970914	79970915	CA	C	distinguished	MSH3	NM_002439.5	7	c.1148del	p.Lys383fs	frameshift_variant	Pathogenic		Endometrial_carcinoma|Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_4|not_provided	36	0.0
	APC(0.3%)	exon4,c.376G>A,p.G126R	0.002573	0.001973	3091|8	657|0	0.00182	4924|9	5	112103041	112103041	G	A	low_allele_frac	APC	NM_000038.6	4	c.376G>A	p.Gly126Arg	missense_variant				39	0.0
-	APC(12.5%)	exon5,c.423-5_423-4del	0.125	0.043	100|30	49|1	0.13993	252|41	5	112111309	112111311	TAA	T	germline,multiallelic,normal_artifact	APC	NM_000038.6	4	c.423-5_423-4del		splice_region_variant&intron_variant	Likely_benign		Hereditary_cancer-predisposing_syndrome	44	0.0
-	APC(45.9%)	exon5,c.423-4del	0.459	0.141	100|110	49|8	0.42202	252|184	5	112111309	112111311	TAA	TA	germline,multiallelic,normal_artifact,distinguished	APC	NM_000038.6	4	c.423-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Colorectal_cancer|Hereditary_cancer-predisposing_syndrome|Familial_adenomatous_polyposis_1|not_specified|not_provided	35	0.0
-	APC(30.2%)	exon16,c.5390del,p.N1797fs	0.302	0.00814	886|384	377|2	0.29773	1420|602	5	112176675	112176676	CA	C	PASS	APC	NM_000038.6	16	c.5390del	p.Asn1797fs	frameshift_variant				33	0.0
	SNCAIP(3.3%)	exon5,c.1038C>T,p.H346=	0.033	0.038	145|4	29|0	0.02454	159|4	5	121761082	121761082	C	T	suspected_bg	SNCAIP	NM_005460.4	5	c.1038C>T	p.His346=	synonymous_variant				29	0.0
	RAD50(37.5%)	exon13,c.2165del,p.K722fs	0.375	0.057	1316|803	388|30	0.32452	2656|1276	5	131931451	131931452	TA	T	multiallelic,normal_artifact,distinguished	RAD50	NM_005732.4	13	c.2165del	p.Lys722fs	frameshift_variant	Pathogenic		Nijmegen_breakage_syndrome-like_disorder|Hereditary_cancer-predisposing_syndrome	45	0.0
	RAD50(1.0%)	exon13,c.2165dup,p.E723fs	0.009745	0.016	1316|29	388|7	0.02137	2656|58	5	131931451	131931452	TA	TAA	multiallelic,normal_artifact,suspected_bg	RAD50	NM_005732.4	13	c.2165dup	p.Glu723fs	frameshift_variant	Pathogenic		Nijmegen_breakage_syndrome-like_disorder|Hereditary_cancer-predisposing_syndrome|Breast_and/or_ovarian_cancer|not_provided	41	0.0
	TTK(28.6%)	exon22,c.2571del,p.K857fs	0.286	0.013	1216|496	572|8	0.26205	2174|772	6	80751909	80751910	GA	G	distinguished	TTK	NM_003318.5	22	c.2571del	p.Lys857fs	frameshift_variant				41	0.0
	GRIK2(31.4%)	exon16,c.2546del,p.N849fs	0.314	0.015	756|358	383|6	0.29218	1158|478	6	102503431	102503432	CA	C	distinguished	GRIK2	NM_021956.5	16	c.2546del	p.Asn849fs	frameshift_variant				42	0.0
	PRDM1(30.4%)	exon5,c.1313G>A,p.G438D	0.304	0.021	247|109	49|0	0.30515	337|148	6	106553348	106553348	G	A	PASS	PRDM1	NM_001198.4	5	c.1313G>A	p.Gly438Asp	missense_variant				41	0.0
	ROS1(4.8%)	exon23,c.3531G>A,p.T1177=	0.048	0.002733	1686|82	464|0	0.04887	2394|123	6	117681089	117681089	C	T	PASS	ROS1	NM_002944.3	23	c.3531G>A	p.Thr1177=	synonymous_variant	Benign		not_provided	38	0.0
	ESR1(26.1%)	exon7,c.1389C>A,p.S463=	0.261	0.002389	2171|797	525|0	0.27248	3543|1327	6	152415539	152415539	C	A	PASS	ESR1	NM_000125.4	7	c.1389C>A	p.Ser463=	synonymous_variant				35	0.0
2	PMS2(23.0%)	exon7,c.706-7_706-4del	0.23	0.056	9|32	3|0	0.17241	264|55	7	6037057	6037061	GAAAA	G	germline,multiallelic,normal_artifact	PMS2	NM_000535.7	6	c.706-7_706-4del		splice_region_variant&intron_variant	Benign		not_specified	49	0.0
2	PMS2(40.6%)	exon7,c.706-6_706-4del	0.406	0.1	9|51	3|1	0.32308	264|126	7	6037057	6037061	GAAAA	GA	germline,multiallelic,normal_artifact	PMS2	NM_000535.7	6	c.706-6_706-4del		splice_region_variant&intron_variant	Benign		Malignant_tumor_of_breast|Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms|not_specified|not_provided	47	0.0
2	PMS2(29.1%)	exon7,c.706-5_706-4del	0.291	0.52	9|30	3|4	0.28065	264|103	7	6037057	6037061	GAAAA	GAA	germline,multiallelic,normal_artifact	PMS2	NM_000535.7	6	c.706-5_706-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Lynch_syndrome|Colorectal_cancer,_hereditary_nonpolyposis,_type_4|Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms|not_specified	48	0.0
	RSBN1L(2.6%)	exon3,c.1198G>A,p.V400M	0.026	0.002076	3963|117	699|1	0.02939	6440|195	7	77379235	77379235	G	A	PASS	RSBN1L	NM_198467.3	3	c.1198G>A	p.Val400Met	missense_variant				37	0.0
	MET(17.3%)	exon11,c.2398T>G,p.C800G	0.173	0.0008436	4274|924	1492|0	0.17065	8981|1848	7	116403137	116403137	T	G	PASS	MET	NM_000245.4	11	c.2398T>G	p.Cys800Gly	missense_variant				42	0.0
	BRAF(1.1%)	exon10,c.1208del,p.P403fs	0.011	0.00706	1393|23	284|5	0.00946	2304|22	7	140482926	140482927	AG	A	suspected_bg	BRAF	NM_004333.6	10	c.1208del	p.Pro403fs	frameshift_variant				47	0.0
-	KMT2C(1.7%)	exon38,c.8390dup,p.E2798fs	0.017	0.021	7372|173	1636|50	0.03058	19369|611	7	151874147	151874148	CT	CTT	multiallelic,normal_artifact,slippage,suspected_bg	KMT2C	NM_170606.3	38	c.8390dup	p.Glu2798fs	frameshift_variant	Pathogenic		not_provided	40	0.0
	KMT2C(18.8%)	exon38,c.8012C>T,p.T2671M	0.188	0.005048	1386|321	263|0	0.19794	1714|423	7	151874526	151874526	G	A	PASS	KMT2C	NM_170606.3	38	c.8012C>T	p.Thr2671Met	missense_variant				40	0.0
	KMT2C(2.1%)	exon34,c.5053G>T,p.A1685S	0.021	0.024	276|6	52|0	0.01554	380|6	7	151882672	151882672	C	A	background	KMT2C	NM_170606.3	34	c.5053G>T	p.Ala1685Ser	missense_variant	Benign		not_provided	35	0.0
	PRKDC(29.4%)	exon72,c.10101G>T,p.E3367D	0.294	0.056	84|32	18|0	0.24806	97|32	8	48713366	48713366	C	A	PASS	PRKDC	NM_006904.7	72	c.10101G>T	p.Glu3367Asp	missense_variant				37	0.0
	RUNX1T1(3.8%)	exon11,c.1467C>T,p.C489=	0.038	0.023	284|10	56|0	0.03509	330|12	8	92972707	92972707	G	A	PASS	RUNX1T1	NM_175635.3	11	c.1467C>T	p.Cys489=	synonymous_variant				28	0.0
	RUNX1T1(2.0%)	exon6,c.777A>C,p.P259=	0.02	0.03	263|10	38|0	0.03785	305|12	8	93003970	93003970	T	G	suspected_bg	RUNX1T1	NM_175635.3	6	c.777A>C	p.Pro259=	synonymous_variant				34	0.0
	UBR5(2.1%)	exon45,c.6360del,p.E2121fs	0.021	0.005485	6881|199	1478|11	0.02535	16761|436	8	103289348	103289349	CT	C	haplotype,slippage,suspected_bg	UBR5	NM_015902.6	45	c.6360del	p.Glu2121fs	frameshift_variant				41	0.0
	JAK2(3.4%)	exon21,c.2819A>G,p.Y940C	0.034	0.011	564|19	123|0	0.02945	692|21	9	5090503	5090503	A	G	PASS	JAK2	NM_004972.4	21	c.2819A>G	p.Tyr940Cys	missense_variant				32	0.0
	NTRK2(2.5%)	exon17,c.2067G>A,p.V689=	0.025	0.0007715	6869|187	1601|0	0.02754	16172|458	9	87570327	87570327	G	A	PASS	NTRK2	NM_006180.6	17	c.2067G>A	p.Val689=	synonymous_variant				47	0.0
	PTCH1(25.0%)	exon2,c.338C>T,p.A113V	0.25	0.048	111|34	27|0	0.25157	119|40	9	98268745	98268745	G	A	PASS	PTCH1	NM_000264.5	2	c.338C>T	p.Ala113Val	missense_variant				42	0.0
	PTCH1(22.1%)	exon1,c.118C>T,p.R40C	0.221	0.125	70|21	7|0	0.27434	82|31	9	98270526	98270526	G	A	PASS	PTCH1	NM_000264.5	1	c.118C>T	p.Arg40Cys	missense_variant	Uncertain_significance		Gorlin_syndrome	32	0.0
	PPP6C(22.7%)	exon7,c.850T>C,p.L284=	0.227	0.002779	1658|486	446|0	0.21854	2689|752	9	127912020	127912020	A	G	PASS	PPP6C	NM_002721.5	7	c.850T>C	p.Leu284=	synonymous_variant				40	0.0
	ABL1(19.8%)	exon4,c.747C>T,p.G249=	0.198	0.008674	622|159	128|0	0.23629	724|224	9	133738347	133738347	C	T	PASS	ABL1	NM_005157.6	4	c.747C>T	p.Gly249=	synonymous_variant				39	0.0
	NOTCH1(28.9%)	exon25,c.4081G>A,p.G1361S	0.289	0.084	37|17	11|0	0.31667	41|19	9	139400267	139400267	C	T	PASS	NOTCH1	NM_017617.5	25	c.4081G>A	p.Gly1361Ser	missense_variant				19	0.0
	NOTCH1(27.1%)	exon21,c.3395G>A,p.R1132H	0.271	0.143	53|19	6|0	0.28571	55|22	9	139402522	139402522	C	T	PASS	NOTCH1	NM_017617.5	21	c.3395G>A	p.Arg1132His	missense_variant	Uncertain_significance		not_provided	22	0.0
	GATA3(26.1%)	exon6,c.1262C>T,p.T421M	0.261	0.017	274|98	78|0	0.27378	313|118	10	8115913	8115913	C	T	PASS	GATA3	NM_001002295.2	6	c.1262C>T	p.Thr421Met	missense_variant	Likely_pathogenic		Hypoparathyroidism,_deafness,_renal_disease_syndrome	41	0.0
	TRIM51(11.1%)	exon3,c.430del,p.M144fs	0.111	0.015	1513|201	337|8	0.11006	2361|292	11	55653609	55653610	TA	T	slippage,distinguished	TRIM51	NM_032681.4	3	c.430del	p.Met144fs	frameshift_variant				36	0.0
	OR8I2(3.2%)	exon1,c.783T>C,p.P261=	0.032	0.004329	1044|34	305|0	0.03055	1523|48	11	55861566	55861566	T	C	PASS	OR8I2	NM_001003750.1	1	c.783T>C	p.Pro261=	synonymous_variant				39	0.0
	MEN1(25.6%)	exon9,c.1259G>A,p.R420Q	0.256	0.111	79|31	8|0	0.28455	88|35	11	64572612	64572612	C	T	PASS	MEN1	NM_000244.3	9	c.1259G>A	p.Arg420Gln	missense_variant	Uncertain_significance		Multiple_endocrine_neoplasia,_type_1	44	0.0
-	ATM(23.8%)	exon6,c.497-7_497-4del	0.238	0.062	11|32	11|0	0.30968	107|48	11	108114661	108114665	ATTTT	A	multiallelic	ATM	NM_000051.4	5	c.497-7_497-4del		splice_region_variant&intron_variant				43	0.0
-	ATM(38.4%)	exon6,c.497-6_497-4del	0.384	0.062	11|55	11|0	0.53275	107|122	11	108114661	108114665	ATTTT	AT	multiallelic	ATM	NM_000051.4	5	c.497-6_497-4del		splice_region_variant&intron_variant				36	0.0
-	ATM(29.2%)	exon6,c.497-5_497-4del	0.292	0.139	11|32	11|1	0.43979	107|84	11	108114661	108114665	ATTTT	ATT	multiallelic	ATM	NM_000051.4	5	c.497-5_497-4del		splice_region_variant&intron_variant	Likely_benign		Hereditary_cancer-predisposing_syndrome	36	0.0
	CD3G(3.9%)	exon3,c.213del,p.K71fs	0.039	0.025	1287|64	230|7	0.04401	2172|100	11	118220582	118220583	TA	T	multiallelic,normal_artifact,slippage,suspected_bg	CD3G	NM_000073.3	3	c.213del	p.Lys71fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(1)|_Uncertain_significance(1)	Combined_immunodeficiency_due_to_CD3gamma_deficiency	45	0.0
	CD3G(3.3%)	exon3,c.213dup,p.W72fs	0.033	0.018	1287|61	230|5	0.04779	2172|109	11	118220582	118220583	TA	TAA	multiallelic,normal_artifact,slippage,distinguished	CD3G	NM_000073.3	3	c.213dup	p.Trp72fs	frameshift_variant	Pathogenic		Combined_immunodeficiency_due_to_CD3gamma_deficiency	45	0.0
	SRPRA(4.5%)	exon4,c.509del,p.K170fs	0.045	0.004007	5546|331	1213|8	0.04973	14714|770	11	126137086	126137087	CT	C	clustered_events,multiallelic,slippage,distinguished	SRPRA	NM_003139.4	4	c.509del	p.Lys170fs	frameshift_variant				45	0.0
	KDM5A(31.0%)	exon23,c.3597del,p.G1200fs	0.31	0.019	559|266	136|3	0.30051	824|354	12	416952	416953	CT	C	multiallelic,distinguished	KDM5A	NM_001042603.3	23	c.3597del	p.Gly1200fs	frameshift_variant				37	0.0
	KDM5A(2.2%)	exon23,c.3597dup,p.G1200fs	0.022	0.008777	559|27	136|0	0.03513	824|30	12	416952	416953	CT	CTT	multiallelic,suspected_bg	KDM5A	NM_001042603.3	23	c.3597dup	p.Gly1200fs	frameshift_variant				41	0.0
	CCND2(30.1%)	exon5,c.801C>T,p.D267=	0.301	0.012	504|223	104|0	0.32940	625|307	12	4409106	4409106	C	T	PASS	CCND2	NM_001759.4	5	c.801C>T	p.Asp267=	synonymous_variant	Likely_benign		not_provided	36	0.0
1	KRAS(0.1%)	exon3,c.175G>A,p.A59T	0.001084	0.001152	4816|4	1722|1	0.00058	11982|7	12	25380283	25380283	C	T	clustered_events,weak_evidence	KRAS	NM_033360.4	3	c.175G>A	p.Ala59Thr	missense_variant	Pathogenic/Likely_pathogenic		Neoplasm_of_the_large_intestine|Bladder_cancer,_transitional_cell,_somatic	23	0.0
1	KRAS(0.1%)	exon2,c.34G>A,p.G12S	0.001214	0.00156	6605|7	1929|3	0.00110	17227|19	12	25398285	25398285	C	T	clustered_events,weak_evidence	KRAS	NM_033360.4	2	c.34G>A	p.Gly12Ser	missense_variant	Pathogenic		Gastric_cancer|Juvenile_myelomonocytic_leukemia|Non-small_cell_lung_carcinoma|Thyroid_tumor|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|RASopathy|not_provided	35	0.0
	ARID2(2.3%)	exon5,c.462G>A,p.S154=	0.023	0.006045	851|19	231|0	0.02443	1198|30	12	46211496	46211496	G	A	PASS	ARID2	NM_152641.4	5	c.462G>A	p.Ser154=	synonymous_variant				56	0.0
-	ARID2(29.4%)	exon15,c.3110_3113dup,p.M1038fs	0.294	0.028	200|75	43|0	0.22943	309|92	12	46245015	46245015	C	CAGAT	PASS	ARID2	NM_152641.4	15	c.3110_3113dup	p.Met1038fs	frameshift_variant				30	0.0
	KMT2D(31.2%)	exon49,c.15088C>T,p.R5030C	0.312	0.066	101|45	15|0	0.30263	106|46	12	49420661	49420661	G	A	distinguished	KMT2D	NM_003482.4	49	c.15088C>T	p.Arg5030Cys	missense_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(2)|_Likely_pathogenic(1)|_Uncertain_significance(1)	Kabuki_syndrome_1|Kabuki_syndrome|not_provided	38	0.0
-	KMT2D(34.9%)	exon37,c.10394del,p.G3465fs	0.349	0.091	77|37	10|0	0.31210	108|49	12	49428410	49428411	TC	T	PASS	KMT2D	NM_003482.4	37	c.10394del	p.Gly3465fs	frameshift_variant	Pathogenic		Kabuki_syndrome_1	33	0.0
	KMT2D(32.6%)	exon35,c.8539C>T,p.R2847C	0.326	0.025	201|93	46|0	0.33636	219|111	12	49432600	49432600	G	A	PASS	KMT2D	NM_003482.4	35	c.8539C>T	p.Arg2847Cys	missense_variant	Uncertain_significance		Kabuki_syndrome	37	0.0
-	KMT2D(5.6%)	exon24,c.5320-2A>C	0.056	0.059	81|6	16|0	0.05714	99|6	12	49437567	49437567	T	G	PASS	KMT2D	NM_003482.4	23	c.5320-2A>C		splice_acceptor_variant&intron_variant				57	0.0
	TBX3(44.1%)	exon6,c.1546G>A,p.A516T	0.441	0.161	11|10	4|0	0.44828	16|13	12	115112134	115112134	C	T	PASS	TBX3	NM_005996.4	6	c.1546G>A	p.Ala516Thr	missense_variant				18	0.0
-	HNF1A(33.4%)	exon4,c.872del,p.P291fs	0.334	0.167	37|16	4|0	0.26984	46|17	12	121432117	121432118	GC	G	slippage,distinguished	HNF1A	NM_000545.8	4	c.872del	p.Pro291fs	frameshift_variant	Pathogenic		Monogenic_diabetes|not_provided	36	0.0
-	HNF1A(41.6%)	exon8,c.1502-6G>A	0.416	0.1	20|11	11|0	0.40625	19|13	12	121437065	121437065	G	A	PASS	HNF1A	NM_000545.8	7	c.1502-6G>A		splice_region_variant&intron_variant	Pathogenic		Maturity_onset_diabetes_mellitus_in_young|Maturity-onset_diabetes_of_the_young_type_3	34	0.0
	HNF1A(18.2%)	exon8,c.1557G>A,p.P519=	0.182	0.091	38|8	14|0	0.18750	39|9	12	121437126	121437126	G	A	PASS	HNF1A	NM_000545.8	8	c.1557G>A	p.Pro519=	synonymous_variant				40	0.0
	POLE(27.8%)	exon37,c.4737C>T,p.R1579=	0.278	0.089	59|23	13|0	0.27778	65|25	12	133219307	133219307	G	A	PASS	POLE	NM_006231.4	37	c.4737C>T	p.Arg1579=	synonymous_variant				37	0.0
	BRCA2(27.9%)	exon11,c.3208G>A,p.A1070T	0.279	0.001168	2355|915	1166|0	0.28618	4345|1742	13	32911700	32911700	G	A	PASS	BRCA2	NM_000059.4	11	c.3208G>A	p.Ala1070Thr	missense_variant	Uncertain_significance		Hereditary_cancer-predisposing_syndrome|not_provided	42	0.0
-	BRCA2(1.4%)	exon11,c.5073del,p.K1691fs	0.014	0.014	1646|30	488|7	0.01553	2535|40	13	32913558	32913559	CA	C	normal_artifact,suspected_bg	BRCA2	NM_000059.4	11	c.5073del	p.Lys1691fs	frameshift_variant	Pathogenic		Breast-ovarian_cancer,_familial,_susceptibility_to,_2|not_provided	51	0.0
	NBEA(0.9%)	exon22,c.3362del,p.N1121fs	0.009335	0.006201	2158|26	742|4	0.01036	3820|40	13	35733662	35733663	TA	T	slippage,suspected_bg	NBEA	NM_015678.5	22	c.3362del	p.Asn1121fs	frameshift_variant	Likely_pathogenic		Neurodevelopmental_disorder_with_or_without_early-onset_generalized_epilepsy	54	0.0
-	RB1(3.9%)	exon7,c.608-4del	0.039	0.027	4474|211	1810|55	0.03709	14720|567	13	48934140	48934141	AT	A	multiallelic,normal_artifact,slippage,suspected_bg	RB1	NM_000321.3	6	c.608-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Retinoblastoma|Hereditary_cancer-predisposing_syndrome|not_provided	37	0.0
-	RB1(3.1%)	exon7,c.608-4dup	0.031	0.021	4474|180	1810|50	0.03916	14720|600	13	48934140	48934141	AT	ATT	multiallelic,normal_artifact,slippage,suspected_bg	RB1	NM_000321.3	6	c.608-4dup		splice_region_variant&intron_variant	Benign		Retinoblastoma|Hereditary_cancer-predisposing_syndrome	34	0.0
-	RB1(0.4%)	exon7,c.608-3C>T	0.004144	0.003211	5194|25	2060|10	0.00437	16856|74	13	48934150	48934150	C	T	normal_artifact,low_allele_frac	RB1	NM_000321.3	6	c.608-3C>T		splice_region_variant&intron_variant				43	0.0
	EBPL(0.6%)	exon4,c.516T>A,p.F172L	0.006348	0.00672	1384|10	202|2	0.05208	2184|120	13	50235209	50235209	A	T	low_allele_frac	EBPL	NM_032565.5	4	c.516T>A	p.Phe172Leu	missense_variant				37	0.0
	PHGR1(2.7%)	exon4,c.109del,p.H37fs	0.027	0.026	296|8	33|0	0.01789	494|9	15	40648357	40648358	AC	A	suspected_bg	PHGR1	NM_001145643.2	4	c.109del	p.His37fs	frameshift_variant				38	0.0
	MINAR1(2.5%)	exon2,c.2104del,p.S702fs	0.025	0.04	249|7	34|1	0.01170	338|4	15	79750585	79750586	TA	T	multiallelic,slippage,suspected_bg	MINAR1	NM_015206.3	2	c.2104del	p.Ser702fs	frameshift_variant				44	0.0
	MINAR1(3.1%)	exon2,c.2104dup,p.S702fs	0.031	0.03	249|8	34|0	0.02029	338|7	15	79750585	79750586	TA	TAA	multiallelic,slippage,suspected_bg	MINAR1	NM_015206.3	2	c.2104dup	p.Ser702fs	frameshift_variant				37	0.0
	BLM(28.4%)	exon7,c.1544del,p.N515fs	0.284	0.024	2011|804	642|17	0.27273	3544|1329	15	91304138	91304139	GA	G	distinguished	BLM	NM_000057.4	7	c.1544del	p.Asn515fs	frameshift_variant	Pathogenic		Bloom_syndrome	41	0.0
	CHD2(6.0%)	exon29,c.3734del,p.K1245fs	0.06	0.1	510|36	85|12	0.06390	835|57	15	93540315	93540316	GA	G	normal_artifact,slippage,suspected_bg	CHD2	NM_001271.4	29	c.3734del	p.Lys1245fs	frameshift_variant&splice_region_variant	Conflicting_interpretations_of_pathogenicity	Pathogenic(3)|_Likely_pathogenic(1)|_Uncertain_significance(1)	Developmental_and_epileptic_encephalopathy_94|History_of_neurodevelopmental_disorder|not_specified|not_provided	41	0.0
	CHD2(3.7%)	exon33,c.4173del,p.K1391fs	0.037	0.025	184|7	41|0	0.03642	291|11	15	93545433	93545434	GA	G	slippage,suspected_bg	CHD2	NM_001271.4	33	c.4173del	p.Lys1391fs	frameshift_variant	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(1)|_Uncertain_significance(1)	Intellectual_disability|not_specified	27	0.0
	IGF1R(11.9%)	exon4,c.1055G>A,p.G352E	0.119	0.021	238|35	51|0	0.12336	334|47	15	99440087	99440087	G	A	PASS	IGF1R	NM_000875.5	4	c.1055G>A	p.Gly352Glu	missense_variant				39	0.0
	GRIN2A(23.3%)	exon13,c.3953G>A,p.R1318Q	0.233	0.084	112|35	13|0	0.28652	127|51	16	9857448	9857448	C	T	PASS	GRIN2A	NM_001134407.3	13	c.3953G>A	p.Arg1318Gln	missense_variant	Likely_benign		Landau-Kleffner_syndrome	44	0.0
	PALB2(30.4%)	exon4,c.839del,p.N280fs	0.304	0.004143	999|426	291|1	0.28578	1532|613	16	23647027	23647028	GT	G	PASS	PALB2	NM_024675.4	4	c.839del	p.Asn280fs	frameshift_variant	Pathogenic		Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|not_provided	39	0.0
-	CDH1(0.6%)	exon3,c.377del,p.P126fs	0.00594	0.006766	1983|18	353|2	0.00966	3280|32	16	68835780	68835781	GC	G	strand_bias,weak_evidence,low_allele_frac	CDH1	NM_004360.5	3	c.377del	p.Pro126fs	frameshift_variant	Pathogenic		Hereditary_diffuse_gastric_adenocarcinoma|not_provided	36	0.0
	PLCG2(37.0%)	exon29,c.3305C>T,p.T1102M	0.37	0.083	33|20	12|0	0.35065	50|27	16	81972512	81972512	C	T	PASS	PLCG2	NM_002661.5	29	c.3305C>T	p.Thr1102Met	missense_variant				21	0.0
	TP53(28.7%)	exon8,c.828C>A,p.A276=	0.287	0.002735	3251|1309	855|1	0.29599	6315|2655	17	7577110	7577110	G	T	PASS	TP53	NM_000546.6	8	c.828C>A	p.Ala276=	synonymous_variant				36	0.0
	TP53(28.2%)	exon7,c.700T>C,p.Y234H	0.282	0.007756	678|262	162|0	0.27414	1030|389	17	7577581	7577581	A	G	PASS	TP53	NM_000546.6	7	c.700T>C	p.Tyr234His	missense_variant	Pathogenic		Hepatocellular_carcinoma|Adrenal_cortex_carcinoma|Pancreatic_adenocarcinoma|Transitional_cell_carcinoma_of_the_bladder|Breast_neoplasm|Carcinoma_of_esophagus|Small_cell_lung_carcinoma|Squamous_cell_lung_carcinoma|Gastric_adenocarcinoma|Neoplasm_of_ovary|Neoplasm_of_the_large_intestine|Prostate_adenocarcinoma|Ovarian_serous_cystadenocarcinoma|Squamous_cell_carcinoma_of_the_head_and_neck|Hereditary_cancer-predisposing_syndrome|Glioblastoma|Li-Fraumeni_syndrome	43	0.0
	TP53(30.9%)	exon6,c.644G>A,p.S215N	0.309	0.00221	2538|1160	584|0	0.31830	4988|2329	17	7578205	7578205	C	T	PASS	TP53	NM_000546.6	6	c.644G>A	p.Ser215Asn	missense_variant	Conflicting_interpretations_of_pathogenicity	Likely_pathogenic(1)|_Uncertain_significance(1)	Hepatocellular_carcinoma|Acute_myeloid_leukemia|Pancreatic_adenocarcinoma|Breast_neoplasm|Carcinoma_of_esophagus|Lung_adenocarcinoma|Small_cell_lung_carcinoma|Gastric_adenocarcinoma|Ovarian_serous_cystadenocarcinoma|Hereditary_cancer-predisposing_syndrome|Li-Fraumeni_syndrome	43	0.0
	AURKB(30.6%)	exon9,c.943C>T,p.R315W	0.306	0.021	300|130	55|0	0.31452	340|156	17	8108281	8108281	G	A	PASS	AURKB	NM_004217.4	9	c.943C>T	p.Arg315Trp	missense_variant				33	0.0
-	NF1(3.2%)	exon2,c.61-4del	0.032	0.022	384|13	57|0	0.01313	526|7	17	29482988	29482989	CT	C	haplotype,slippage,suspected_bg	NF1	NM_000267.3	1	c.61-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Neurofibromatosis,_familial_spinal|Caf??-au-lait_macules_with_pulmonary_stenosis|Neurofibromatosis-Noonan_syndrome|Hereditary_cancer-predisposing_syndrome|Neurofibromatosis,_type_1|not_specified|not_provided	48	0.0
	ERBB2(4.2%)	exon3,c.258C>T,p.I86=	0.042	0.023	279|9	44|0	0.04359	373|17	17	37864606	37864606	C	T	PASS	ERBB2	NM_004448.4	3	c.258C>T	p.Ile86=	synonymous_variant	Likely_benign		not_provided	36	0.0
	ERBB2(3.2%)	exon27,c.3694del,p.A1232fs	0.032	0.007323	942|35	146|0	0.03863	1319|53	17	37884217	37884218	CG	C	distinguished	ERBB2	NM_004448.4	27	c.3694del	p.Ala1232fs	frameshift_variant				37	0.0
	XYLT2(32.0%)	exon8,c.1584del,p.G529fs	0.32	0.009988	597|274	130|0	0.29812	970|412	17	48433966	48433967	AC	A	distinguished	XYLT2	NM_022167.4	8	c.1584del	p.Gly529fs	frameshift_variant	Likely_pathogenic		Spondylo-ocular_syndrome	46	0.0
-	RNF43(38.1%)	exon9,c.1976del,p.G659fs	0.381	0.079	161|105	26|1	0.33698	303|154	17	56435160	56435161	AC	A	distinguished	RNF43	NM_017763.6	9	c.1976del	p.Gly659fs	frameshift_variant	Likely_pathogenic		Sessile_serrated_polyposis_cancer_syndrome	42	0.0
-	RNF43(37.1%)	exon9,c.1436_1437del,p.V479fs	0.371	0.089	72|37	10|0	0.36364	91|52	17	56435699	56435701	CCA	C	PASS	RNF43	NM_017763.6	9	c.1436_1437del	p.Val479fs	frameshift_variant				37	0.0
	SMAD4(27.8%)	exon11,c.1314T>C,p.F438=	0.278	0.001808	2670|1021	737|0	0.27497	4828|1831	18	48603013	48603013	T	C	PASS	SMAD4	NM_005359.6	11	c.1314T>C	p.Phe438=	synonymous_variant				30	0.0
	LMAN1(33.9%)	exon8,c.912del,p.E305fs	0.339	0.021	2898|1536	784|24	0.31850	6618|3093	18	57013193	57013194	CT	C	multiallelic,distinguished	LMAN1	NM_005570.4	8	c.912del	p.Glu305fs	frameshift_variant				37	0.0
	DOT1L(11.5%)	exon24,c.2927C>T,p.A976V	0.115	0.143	26|4	6|0	0.13793	25|4	19	2222095	2222095	C	T	PASS	DOT1L	NM_032482.3	24	c.2927C>T	p.Ala976Val	missense_variant				32	0.0
	BRD4(0.7%)	exon8,c.1420C>T,p.P474S	0.00654	0.009096	2395|19	414|4	0.00965	4104|40	19	15367906	15367906	G	A	background,low_allele_frac	BRD4	NM_058243.3	8	c.1420C>T	p.Pro474Ser	missense_variant				41	0.0
	AKT2(2.0%)	exon13,c.1364G>A,p.R455H	0.02	0.028	351|6	46|0	0.01255	472|6	19	40740954	40740954	C	T	orientation	AKT2	NM_001626.6	13	c.1364G>A	p.Arg455His	missense_variant&splice_region_variant				36	0.0
-	CIC(14.9%)	exon14,c.3347dup,p.S1117fs	0.149	0.083	48|7	10|0	0.13265	85|13	19	42796882	42796882	G	GC	PASS	CIC	NM_015125.5	14	c.3347dup	p.Ser1117fs	frameshift_variant				47	0.0
	BAX(4.3%)	exon3,c.121del,p.E41fs	0.043	0.023	779|38	102|1	0.05087	1530|82	19	49458970	49458971	TG	T	slippage,suspected_bg	BAX	NM_138761.4	3	c.121del	p.Glu41fs	frameshift_variant	Pathogenic		Carcinoma_of_colon	46	0.0
	TEAD2(29.2%)	exon10,c.895del,p.H299fs	0.292	0.012	537|229	103|0	0.26829	870|319	19	49850472	49850473	TG	T	distinguished	TEAD2	NM_001256660.2	10	c.895del	p.His299fs	frameshift_variant				39	0.0
	NCOA3(3.1%)	exon20,c.3789_3791del,p.Q1264del	0.031	0.024	348|12	40|2	0.03005	807|25	20	46279836	46279839	ACAG	A	multiallelic,suspected_bg	NCOA3	NM_181659.3	20	c.3789_3791del	p.Gln1264del	disruptive_inframe_deletion				25	0.0
	EP300(30.5%)	exon7,c.1571C>T,p.T524M	0.305	0.014	621|266	95|0	0.29355	811|337	22	41531859	41531859	C	T	PASS	EP300	NM_001429.4	7	c.1571C>T	p.Thr524Met	missense_variant	Likely_benign		not_provided	43	0.0
	EP300(28.7%)	exon31,c.6334G>T,p.G2112W	0.287	0.059	61|27	18|0	0.30097	72|31	22	41574049	41574049	G	T	PASS	EP300	NM_001429.4	31	c.6334G>T	p.Gly2112Trp	missense_variant				34	0.0
	KDM6A(23.0%)	exon16,c.1551G>T,p.Q517H	0.23	0.024	285|87	54|0	0.23702	338|105	X	44922690	44922690	G	T	PASS	KDM6A	NM_021140.4	16	c.1551G>T	p.Gln517His	missense_variant				40	0.0
	KDM6A(8.7%)	exon18,c.2761C>T,p.P921S	0.087	0.019	299|32	63|0	0.08071	467|41	X	44936000	44936000	C	T	PASS	KDM6A	NM_021140.4	18	c.2761C>T	p.Pro921Ser	missense_variant				36	0.0
	AMER1(24.2%)	exon2,c.3065G>A,p.R1022H	0.242	0.053	89|31	19|0	0.27143	102|38	X	63410102	63410102	C	T	PASS	AMER1	NM_152424.4	2	c.3065G>A	p.Arg1022His	missense_variant				44	0.0
	AMER1(2.9%)	exon2,c.1600G>T,p.E534*	0.029	0.009593	1045|32	130|1	0.03049	1431|45	X	63411567	63411567	C	A	PASS	AMER1	NM_152424.4	2	c.1600G>T	p.Glu534*	stop_gained				35	0.0
	MED12(30.5%)	exon7,c.855G>A,p.G285=	0.305	0.076	65|25	14|0	0.25472	79|27	X	70341420	70341420	G	A	PASS	MED12	NM_005120.3	7	c.855G>A	p.Gly285=	synonymous_variant				43	0.0
	ATRX(2.5%)	exon33,c.7002A>G,p.K2334=	0.025	0.016	225|5	74|0	0.01916	256|5	X	76776950	76776950	T	C	distinguished	ATRX	NM_000489.6	33	c.7002A>G	p.Lys2334=	synonymous_variant				33	0.0
	ATRX(8.3%)	exon9,c.1841G>A,p.G614D	0.083	0.019	231|19	56|0	0.07612	267|22	X	76938907	76938907	C	T	PASS	ATRX	NM_000489.6	9	c.1841G>A	p.Gly614Asp	missense_variant				35	0.0
	ATRX(2.7%)	exon9,c.1537T>A,p.L513I	0.027	0.017	301|8	76|0	0.03797	380|15	X	76939211	76939211	A	T	PASS	ATRX	NM_000489.6	9	c.1537T>A	p.Leu513Ile	missense_variant				47	0.0
	STAG2(31.8%)	exon5,c.158A>G,p.K53R	0.318	0.048	78|32	22|0	0.27778	91|35	X	123164845	123164845	A	G	PASS	STAG2	NM_001042749.2	5	c.158A>G	p.Lys53Arg	missense_variant				34	0.0
